46,369 Shares in Semler Scientific Inc. $SMLR Purchased by Pinnacle Wealth Management LLC

Pinnacle Wealth Management LLC purchased a new position in Semler Scientific Inc. (NASDAQ:SMLR) in the second quarter, according to its most recent filing with the Securities & Exchange Commission. The firm purchased 46,369 shares of the company’s stock, valued at approximately $1,796,000. Pinnacle Wealth Management LLC owned approximately 0.34% of Semler Scientific as of its most recent filing with the Securities & Exchange Commission.

A number of other hedge funds have also bought and sold shares of SMLR. Interchange Capital Partners LLC acquired a new position in Semler Scientific in the first quarter worth about $46,502,000. Charles Schwab Investment Management Inc. grew its stake in Semler Scientific by 226.1% in the first quarter. Charles Schwab Investment Management Inc. now owns 158,576 shares of the company’s stock worth $5,740,000 after purchasing an additional 109,951 shares in the last quarter. Generali Asset Management SPA SGR acquired a new position in Semler Scientific in the second quarter worth about $2,712,000. Deltec Asset Management LLC grew its stake in Semler Scientific by 112.0% in the second quarter. Deltec Asset Management LLC now owns 100,932 shares of the company’s stock worth $3,910,000 after purchasing an additional 53,332 shares in the last quarter. Finally, Pacer Advisors Inc. acquired a new position in Semler Scientific in the first quarter worth about $1,874,000. 49.37% of the stock is currently owned by institutional investors and hedge funds.

Wall Street Analysts Forecast Growth

A number of equities analysts recently commented on the company. Cantor Fitzgerald decreased their price target on Semler Scientific from $61.00 to $60.00 and set an “overweight” rating for the company in a research note on Wednesday, August 6th. Benchmark decreased their price target on Semler Scientific from $101.00 to $86.00 and set a “buy” rating for the company in a research note on Tuesday, September 23rd. Maxim Group decreased their price target on Semler Scientific from $95.00 to $80.00 and set a “buy” rating for the company in a research note on Friday, September 19th. Finally, Weiss Ratings reissued a “hold (c)” rating on shares of Semler Scientific in a report on Wednesday, October 8th. Four research analysts have rated the stock with a Buy rating and one has given a Hold rating to the company’s stock. Based on data from MarketBeat.com, the stock presently has an average rating of “Moderate Buy” and an average price target of $74.25.

Semler Scientific Stock Performance

Shares of NASDAQ SMLR opened at $23.18 on Friday. The company has a quick ratio of 0.58, a current ratio of 0.60 and a debt-to-equity ratio of 0.25. The firm’s 50-day moving average price is $29.79 and its two-hundred day moving average price is $34.33. Semler Scientific Inc. has a 52-week low of $22.59 and a 52-week high of $81.56. The stock has a market capitalization of $350.95 million, a P/E ratio of 9.54 and a beta of 1.41.

Semler Scientific (NASDAQ:SMLR) last issued its earnings results on Monday, August 4th. The company reported $5.04 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of ($0.27) by $5.31. Semler Scientific had a net margin of 86.20% and a return on equity of 43.84%. The firm had revenue of $8.22 million for the quarter, compared to analysts’ expectations of $8.10 million.

About Semler Scientific

Semler Scientific, Inc provides technology solutions to enhance the clinical effectiveness and efficiency of healthcare providers in the United States. The company’s products include QuantaFlo, a four-minute in-office blood flow test that enables healthcare providers to use blood flow measurements as part of their examinations of a patient’s vascular condition.